StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by johnny007on Feb 05, 2018 5:44pm

86 Views

Post# 27507232

20d VWMA 0.1551 -> 0.2327 for Milost now

20d VWMA and the T-Line 8d EMA is aligned.
20d MA below 40d MA for 2d now.
Waiting game.

Rory Rigg's seems to be all set to average down to 0.55, great.
Milost should finally buy :)

Worried? Not so much.
These plays are market agnostic.
Cheap for the potential.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta